Next Article in Journal
Do AutoML-Based QSAR Models Fulfill OECD Principles for Regulatory Assessment? A 5-HT1A Receptor Case
Next Article in Special Issue
Retinal Delivery of the Protein Kinase C-β Inhibitor Ruboxistaurin Using Non-Invasive Nanoparticles of Polyamidoamine Dendrimers
Previous Article in Journal
Mg2+ Ions Regulating 3WJ-PRNA to Construct Controllable RNA Nanoparticle Drug Delivery Platforms
Previous Article in Special Issue
Combined Transcriptomic and Proteomic Profiling to Unravel Osimertinib, CARP-1 Functional Mimetic (CFM 4.17) Formulation and Telmisartan Combo Treatment in NSCLC Tumor Xenografts
 
 
Review

Article Versions Notes

Pharmaceutics 2022, 14(7), 1414; https://doi.org/10.3390/pharmaceutics14071414
Action Date Notes Link
article xml file uploaded 6 July 2022 07:41 CEST Original file -
article xml uploaded. 6 July 2022 07:41 CEST Update https://www.mdpi.com/1999-4923/14/7/1414/xml
article pdf uploaded. 6 July 2022 07:41 CEST Version of Record https://www.mdpi.com/1999-4923/14/7/1414/pdf
article html file updated 6 July 2022 07:42 CEST Original file -
article html file updated 13 August 2022 00:22 CEST Update https://www.mdpi.com/1999-4923/14/7/1414/html
Back to TopTop